Small molecule C381 targets the lysosome to reduce inflammation and ameliorate disease in models of neurodegeneration
Authors:
Open Access
- 8 March 2022
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (11)
Abstract
Significance: Neurodegenerative diseases are poorly understood and difficult to treat. One common hallmark is lysosomal dysfunction leading to the accumulation of aggregates and other undegradable materials, which cause damage to brain resident cells. Lysosomes are acidic organelles responsible for breaking down biomolecules and recycling their constitutive parts. In this work, we find that the antiinflammatory and neuroprotective compound, discovered via a phenotypic screen, imparts its beneficial effects by targeting the lysosome and restoring its function. This is established using a genome-wide CRISPRi target identification screen and then confirmed using a variety of lysosome-targeted studies. The resulting small molecule from this study represents a potential treatment for neurodegenerative diseases as well as a research tool for the study of lysosomes in disease.Keywords
Funding Information
- HHS | NIH | National Institute on Aging (AG054407)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (NS092868)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (NS057496)
- Glenn Foundation for Medical Research (fellowship)
- Life Sciences Research Foundation (fellowship)
- Michael J. Fox Foundation for Parkinson''''s Research (grant)
- Michael J. Fox Foundation for Parkinson''''s Research (ASAP)
This publication has 80 references indexed in Scilit:
- Core features of frontotemporal dementia recapitulated in progranulin knockout miceNeurobiology of Disease, 2012
- Regulation and Isoform Function of the V-ATPasesBiochemistry, 2010
- Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike PropertiesACS Chemical Neuroscience, 2010
- Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in α-Synuclein Models of Parkinson's and Lewy Body DiseasesJournal of Neuroscience, 2009
- The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid β accumulation in miceJournal of Clinical Investigation, 2008
- Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegenerationProceedings of the National Academy of Sciences, 2006
- Deficiency in neuronal TGF-β signaling promotes neurodegeneration and Alzheimer’s pathologyJournal of Clinical Investigation, 2006
- Altered subcellular location of phosphorylated Smads in Alzheimer's diseaseEuropean Journal of Neuroscience, 2006
- The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin geneBrain, 2006
- Ectopic expression of phospho‐Smad2 in Alzheimer's disease: Uncoupling of the transforming growth factor‐β pathway?Journal of Neuroscience Research, 2006